Amit Dutt

Dr Amit Dutt is a basic scientist at ACTREC, Tata Memorial Centre, Mumbai. He obtained his PhD from the University of Zurich, Switzerland, and ICGEB/ JMI, New Delhi. He was a postdoctoral fellow at the Broad Institute of Harvard and MIT. His laboratory focuses on understanding the somatic changes that occur in human cancer cells and how these changes can help develop the next generation of effective targeted therapies to improve the treatment of cancer patients. The group specifically focuses on the genomic features of genetic alterations underlying oncogenesis and cancer progression in the lung, breast, cervical, gallbladder, head and neck, and others cancers. The efforts involve using advanced sequencing methodologies followed by functional validation to study the implications of genetic alterations in identifying novel cancer dependencies, therapeutic strategies, and biomarkers. Dr Dutt serves on the Editorial Board of PLOS ONE, BMC Genomics, Swiss Medical Weekly, Frontiers Oncology; on the scientific advisory committee and screening/ selection committee of various government and private organizations; and faculty member in Medical Genetics- F1000 Prime. He is a recipient of the Swiss National Science Foundation fellowship award; the Julius Klaus Foundation award from the University of Zurich; the Ramalingaswami Fellowship Award from the Department of Biotechnology (DBT); the Wellcome Trust/ DBT India Alliance Intermediate Fellowship Award; YIM Boston Young Scientist Award; Outstanding Alumni award from JMI, and the Shanti Swarup Bhatnagar Award in the field of Medical Sciences 2017.